Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.
AUTOR(ES)
Noguchi, M
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1234605Documentos Relacionados
- Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.
- Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
- Mutations in p53 as potential molecular markers for human breast cancer.
- Genetic basis for p53 overexpression in human breast cancer.
- Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells.